Erectile dysfunction (ED) is common in men with Parkinson's disease (PD), especially in elderly, and depressive symptoms are also reported in patients with PD. One can observe in the everyday practice that elderly parkinsonian patients can show depression correlated even to ED. The purpose of our study was to evaluate the efficacy of sildenafil, an orally active agent for the treatment of ED in elderly patients with PD, with moderate depression, associated to ED and treated only with dopamine agonist (pramipexole) (Hoehn-Yahr stage 1-2).
Sildefanil in the treatment of erectile dysfunction in elderly depressed patients with idiopathic parkinson disease
GIAMMUSSO B;RUGGIERI, MARTINO;MALAGUARNERA, Mariano;
2002-01-01
Abstract
Erectile dysfunction (ED) is common in men with Parkinson's disease (PD), especially in elderly, and depressive symptoms are also reported in patients with PD. One can observe in the everyday practice that elderly parkinsonian patients can show depression correlated even to ED. The purpose of our study was to evaluate the efficacy of sildenafil, an orally active agent for the treatment of ED in elderly patients with PD, with moderate depression, associated to ED and treated only with dopamine agonist (pramipexole) (Hoehn-Yahr stage 1-2).File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
arc_gerontol_sildenafil_parkinson_2002.pdf
solo gestori archivio
Tipologia:
Versione Editoriale (PDF)
Licenza:
NON PUBBLICO - Accesso privato/ristretto
Dimensione
662.11 kB
Formato
Adobe PDF
|
662.11 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
